JMCCF yields 1775064.68% · JNJ yields 2.13%● Live data
📍 JMCCF pulled ahead of the other in Year 1
Combined, JMCCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JMCCF + JNJ for your $10,000?
JAMCO Corporation manufactures and sells aircraft interiors, seats, and components in Japan. The company offers aircraft interior products, including galleys and bar counters; lavatories comprising touch-less faucets, counters, mirrors and lights, bidet systems, and touch-less flush switches; galley inserts consisting of steam ovens; and flight deck linings, consoles, and stowage, as well as seats and seat consoles. It also provides aircraft components, which includes heat exchangers and chassis for electronic equipment; aircraft engine parts, such as cooling manifolds, engine pipes, turbine shrouds, and outer transition liner products; and stringers and stiffeners for vertical tails. In addition, the company offers aircraft maintenance services for small-sized aircraft and helicopters and regional aircraft; and aircraft accessories maintenance services for system components, rescue hoists, wheels and brakes, high pressure gas cylinder, emergency evacuation slides, and cabin equipment and atmospheric observation equipment. Further, it provides nondestructive testing, welding, composites, and laser machining services. The company was formerly known as New Japan Aircraft Maintenance Co., Ltd. and changed its name to JAMCO Corporation in June 1988. JAMCO Corporation was incorporated in 1949 and is headquartered in Tachikawa, Japan.
Full JMCCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.